ImmuneOnco to Present at 2021 BIO Digital

Date:2021-06-10 Views:124

    Shanghai, China, June 10, 2021 – ImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd. announced today that it has been selected to deliver a company presentation at 2021 BIO Digital, the premier biotech event. BIO Digital is scheduled June 10-11 & 14-18, 2021.

    Dr. Kathy Yu, VP BD will present ImmuneOnco’s pipeline of proprietary platform-based product candidates targeting a broad range of indications in cancer, including:

(1) IMM01: SIRPα-IgG1FC fusion protein, monospecific anti-CD47 (Phase Ib)

(2) IMM0306: bispecific antibody-trap (mAb-Trap), anti CD47xCD20 (Phase I in China and US)

(3) IMM2902: bispecific antibody-trap (mAb-Trap), anti CD47xHER2 (IND filing accepted by NMPA and IND filing to FDA is targeted for July 2021)

    The presentation will be available to registered attendees at 9 am ET June 10. Attendees at BIO Digital will be able to view ImmuneOnco’s Company Presentation before live meetings in the BIO One-on-One Partnering™ system begin on June 14.